PUBLICATIONS
The Next Big Thing In Drug Development May Be The Ubiquitin Pathway
Date: April 1, 2010Pharmaceutical Approvals Monthly -- Velcade, Millennium's successful first-in-class cancer therapy, is held up as a poster drug for manipulating the ubiquitin system to attack disease. Yet it taps only the most rudimentary process of an elegant and little understood cellular mechanism that some are betting will be the next big source of innovation in drug development.
Download PDF
Prelude To A Kiss Of Death - Carmen Drahl
Ubiquitin Drug Discovery & Diagnostics 2009 – First Annual Conference - Jeffrey G Marblestone
The conference publications will be available for ordering after the Ubiquitin Drug Discovery and Diagnostics 2010 conference. Ordering details will be up shortly. For more information or question, please contact us at sales@ubiquitinconference.com
